Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-02-28 Option Award |
2022-03-02 6:11 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer |
10,400 | $0 | 32,115 (Direct) |
View |
2022-02-02 Tax Withholding |
2022-02-04 4:57 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer |
742 | $45.03 | 21,715 (Direct) |
View |
2022-01-31 Tax Withholding |
2022-02-01 6:46 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer |
210 | $45.94 | 22,457 (Direct) |
View |
2022-01-07 Tax Withholding |
2022-01-11 4:42 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer |
90 | $50.63 | 22,667 (Direct) |
View |
2022-01-05 Tax Withholding |
2022-01-07 4:39 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer |
1,511 | $50.69 | 22,757 (Direct) |
View |
Ownership |
2021-10-07 7:03 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer |
0 | $0 | 105,362 (Direct) |
View |